[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2820 Reported in House (RH)]

                                                 Union Calendar No. 183
114th CONGRESS
  1st Session
                                H. R. 2820

                          [Report No. 114-242]

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                          for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 18, 2015

 Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Jolly, and Mr. 
   Fattah) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

                           September 8, 2015

 Additional sponsors: Mr. Grijalva, Mr. Huelskamp, Mr. Bilirakis, Mr. 
Murphy of Pennsylvania, Mrs. Ellmers of North Carolina, Mr. Roskam, Mr. 
 Harris, Mr. DeFazio, Mr. Aderholt, Mr. Nolan, Mr. Newhouse, Mr. Ross, 
  Mr. Lance, Mr. Barletta, Mr. Burgess, Ms. Eshoo, Mr. Loebsack, Mr. 
                        Hudson, and Ms. Pingree

                           September 8, 2015

Committed to the Committee of the Whole House on the State of the Union 
                       and ordered to be printed

_______________________________________________________________________

                                 A BILL


 
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                          for other purposes.


 


    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

     This Act may be cited as the ``Stem Cell Therapeutic and Research 
Reauthorization Act of 2015''.

SEC. 2. AMENDMENTS TO THE STEM CELL THERAPEUTIC AND RESEARCH ACT OF 
              2005.

    (a) Cord Blood Inventory.--Section 2 of the Stem Cell Therapeutic 
and Research Act of 2005 (42 U.S.C. 274k note) is amended in subsection 
(h)--
            (1) in paragraph (1)--
                    (A) by striking ``$23,000,000 for each of fiscal 
                years 2011 through 2014 and''; and
                    (B) by inserting before the period at the end the 
                following: ``and $23,000,000 for each of fiscal years 
                2016 through 2020''; and
            (2) in paragraph (2), by striking ``2011 through 2015'' and 
        inserting ``2015 through 2020''.
    (b) National Program.--Section 379B of the Public Health Service 
Act (42 U.S.C. 274m) is amended by striking ``2011 through 2014'' and 
inserting ``2016 through 2020''.
                                                 Union Calendar No. 183

114th CONGRESS

  1st Session

                               H. R. 2820

                          [Report No. 114-242]

_______________________________________________________________________

                                 A BILL

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                          for other purposes.

_______________________________________________________________________

                           September 8, 2015

Committed to the Committee of the Whole House on the State of the Union 
                       and ordered to be printed